Alexander Kuo
Overview
Explore the profile of Alexander Kuo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1497
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hao D, Dodge R, Kuo A, Baker K, Saddawi-Konefka D
Interv Pain Med
. 2025 Feb;
4(1):100543.
PMID: 39911986
No abstract available.
2.
Shiffman M, Da B, Goel A, Kwong A, Stein L, Moreno C, et al.
NEJM Evid
. 2025 Jan;
4(2):EVIDoa2400243.
PMID: 39873544
Background: Larsucosterol is a DNA methyltransferase inhibitor in development for alcohol-associated hepatitis (AH), a disease for which there is no approved therapy. Methods: In this phase 2b trial, patients with...
3.
Hebson C, Muterspaw K, Kuo A, Borasino P, Syeda K, Anderson T
J Prim Care Community Health
. 2024 Nov;
15:21501319241299527.
PMID: 39540412
Orthostatic intolerance (and its subtype postural orthostatic tachycardia syndrome [POTS]) is an increasingly common complaint among adolescents associated with significant decrease in quality of life and frequent visits to primary...
4.
Kaur B, Yeo Y, Liang J, Luu M, Ayoub W, Kuo A, et al.
Gastro Hep Adv
. 2024 Aug;
3(2):230-237.
PMID: 39129956
Background And Aims: The change in hepatocellular carcinoma (HCC) care continuum during the coronavirus disease 2019 (COVID-19) pandemic remains unknown at a national level in the United States. We sought...
5.
Liang J, Li P, Norman J, Lauzon M, Yeo Y, Trivedi H, et al.
Hepatol Commun
. 2024 Jun;
8(7).
PMID: 38896084
Background: Serum AFP-L3%, AFP, and DCP are useful biomarkers for HCC detection, but their utility in assessing treatment response remains unknown. We aim to evaluate the accuracy of a biomarker...
6.
Niezen S, Goyes D, Vipani A, Yang J, Ayoub W, Kuo A, et al.
J Clin Med
. 2024 Jun;
13(11).
PMID: 38892917
The Hispanic population in the US faces a higher risk of nonalcoholic fatty liver disease (NAFLD). Multiple factors influence this risk, including genetics, environmental factors, and socioeconomic statuses. Inadequate access...
7.
Liang J, Lee Y, Yeo Y, Luu M, Ayoub W, Kuo A, et al.
Clin Transl Gastroenterol
. 2024 Jun;
15(7):e00723.
PMID: 38829967
Introduction: Access to hepatocellular carcinoma (HCC) surveillance and treatments were disrupted during the coronavirus disease 2019 (COVID-19) pandemic. We aimed to characterize the impact of the pandemic on HCC incidence...
8.
Brahmania M, Kuo A, Tapper E, Volk M, Vittorio J, Ghabril M, et al.
Hepatology
. 2024 Mar;
80(3):742-753.
PMID: 38536021
The liver transplantation (LT) evaluation and waitlisting process is subject to variations in care that can impede quality. The American Association for the Study of Liver Diseases (AASLD) Practice Metrics...
9.
Jobin P, Stewart C, Vipani A, Perez-Alvarez I, Pepkowitz S, Klapper E, et al.
ACG Case Rep J
. 2024 Mar;
11(3):e01304.
PMID: 38524265
[This corrects the article DOI: 10.14309/crj.0000000000001246.].
10.
Ho C, Ghabril M, Kuo A, Serper M, Tapper E, Asrani S
Liver Transpl
. 2024 Feb;
30(9):972-975.
PMID: 38381072
No abstract available.